Inactive Instrument

Abnova (Taiwan) Corporation. Share Price Taipei Exchange

Equities

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
- TWD - Intraday chart for Abnova (Taiwan) Corporation.

Financials

Sales 2022 41Cr 1.28Cr 106.09Cr Sales 2023 38Cr 1.19Cr 98Cr Capitalization 212.54Cr 6.59Cr 547.64Cr
Net income 2022 7.4Cr 22.96L 19Cr Net income 2023 4.3Cr 13.34L 11Cr EV / Sales 2022 5.2 x
Net cash position 2022 36Cr 1.1Cr 92Cr Net cash position 2023 42Cr 1.29Cr 107.02Cr EV / Sales 2023 4.48 x
P/E ratio 2022
33.5 x
P/E ratio 2023
48.8 x
Employees -
Yield 2022
1.94%
Yield 2023
2.05%
Free-Float 73.71%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer - 01/18/01
Chairman 58 -
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 60 19/20/19
Chairman 58 -
Director/Board Member 73 23/17/23
More insiders
ABNOVA (TAIWAN) CORPORATION is a Taiwan-based company principally engaged in the manufacturing and sales of antibodies and proteins. The Company's products mainly include monoclonal antibodies, polyclonal antibodies, protein fragments, full-length proteins, active proteins, antibody pairs, fluorescence in situ hybridization probe and others. The Company's monoclonal and polyclonal antibodies are primarily applied in medical testing reagents, agricultural testing, industrial purification, medical treatment and other fields. Its proteins are mainly applied in medical testing reagents, agricultural testing, medical treatment, protein engineering and other fields. Its products are mainly traded in Taiwan, Americas and Europe.
More about the company